Kairos Pharma, Ltd.
KAPA
$0.96
$0.05265.80%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15,219.05% | -47.50% | -56.99% | -6.06% | -57.33% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -41.18% | -10.53% | 137.50% | -52.94% | -34.62% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12,378.95% | -35.59% | -41.58% | -12.93% | -55.04% |
|
|
|||||
| Total Current Assets | 12,378.95% | -35.59% | -41.58% | -12.93% | -55.04% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.25% | -11.70% | -10.47% | -9.48% | -8.66% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 20.84% | 18.46% | 17.56% | 58.91% |
| Total Assets | 385.83% | 5.97% | 0.73% | 1.79% | -3.07% |
|
|
|||||
| Total Accounts Payable | -47.26% | 6.97% | 12.95% | 8.89% | 14.07% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 33.96% | 2,550.00% | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -44.40% | 10.71% | 12.93% | 8.87% | 14.04% |
|
|
|||||
| Total Current Liabilities | -44.40% | 10.71% | 12.93% | 8.87% | 14.04% |
| Long-Term Debt | -- | 3.04% | 2.98% | 4.25% | 1.66% |
| Short-term Debt | 33.96% | 2,550.00% | 0.00% | 0.00% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -54.61% | 9.22% | 10.84% | 7.87% | 11.11% |
|
|
|||||
| Common Stock & APIC | 170.13% | 0.00% | 0.00% | 28.35% | 0.00% |
| Retained Earnings | -15.42% | -3.87% | -5.20% | -21.95% | -6.52% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 225.55% | -10.54% | -15.54% | -10.95% | -19.99% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 225.55% | -10.54% | -15.54% | -10.95% | -19.99% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 225.55% | -10.54% | -15.54% | -10.95% | -19.99% |
|
|
|||||